SCHEMBL10249347

SCHEMBL10249347

CC(C)(C)OC(=O)COCc1ccc(/C(N)=N/O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.38
GAA P10253 4/20 0.38
PPARA Q07869 2/20 0.38
PPARG P37231 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
MAPT P10636 4/20 0.36
NPC1 O15118 4/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
GFER P55789 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
BMP1 P13497 1/20 0.35
PARP10 Q53GL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10246744 0.85 SLC7A5 (0.42) RAB9ANPC1ALDH1A1LMNATP53
SCHEMBL3714654 0.80 HDAC1 (0.41) RAB9AGAAMAPTNPC1ALDH1A1
SCHEMBL3714657 0.80 HDAC1 (0.41) RAB9AGAAMAPTNPC1ALDH1A1
SCHEMBL21068996 0.78 PPARA (0.42) GAAPPARAPPARGMTNR1AMTNR1B
SCHEMBL14917558 0.77 HDAC1 (0.41) RAB9AGAAMTNR1AMTNR1BNPC1
SCHEMBL14917560 0.77 HDAC1 (0.41) RAB9AGAAMTNR1AMTNR1BNPC1
SCHEMBL15270503 0.77 CACNA1B (0.42) RAB9APPARAMAPTNPC1ALDH1A1
SCHEMBL21105498 0.77 PPARA (0.39) GAAPPARAPPARGMTNR1AMTNR1B
SCHEMBL361329 0.77 KMT2A (0.43) PPARAPARP10L3MBTL1KMT2A
SCHEMBL409765 0.76 S1PR1 (0.38) RAB9AGAAMTNR1AMTNR1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414341-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-09-13 EP disclosed
US-8815919-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed
WO-2010115751-A2 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022109-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB RAB9A 4195/4885GAA 3238/4885PPARA 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.